Fairfax Pediatric Doctor Awarded Grant For Heart Transplant Research.

Northern Virginia-based researchers at Inova Schar Heart and Vascular in Fairfax have secured a significant grant of nearly $1.4 million to delve into ways to enhance life expectancy and quality of life for children with transplanted hearts. This initiative, part of a broader $3 million scientific research endeavor by the American Heart Association and Enduring Hearts, aims to develop a novel blood test to fine-tune post-transplant immunosuppression medications for pediatric heart transplant patients. The study, led by Palak Shah, M.D., will focus on utilizing microRNAs to customize medication dosages, ultimately aiming to strike a balance between preventing organ rejection and minimizing complications for young recipients.

This groundbreaking research effort, launched during National Pediatric Transplant Week, seeks to address the challenges faced by the nearly 500 children in the U.S. who undergo heart transplants annually. Inova Schar Heart and Vascular’s dedicated team, in collaboration with Enduring Hearts and the American Heart Association, anticipates making significant strides over the four-year trajectory of this grant. Through innovative solutions and a shared commitment to advancing pediatric heart transplant research, these organizations aim to usher in a new era of personalized care, bolstering the survival and well-being of the youngest recipients within this critical medical domain.


Transplant News
Transplant News

Transplant News brings you the news and content that matters to the transplant community. From patient stories, to the latest in transplant innovation, Transplant News is your window into the world of transplantation.